Document:

ex_111167.htm

Exhibit 4.2.2

 

FIRST AMENDMENT TO

WARRANT TO PURCHASE COMMON STOCK

 

THIS FIRST AMENDMENT TO WARRANT TO PURCHASE COMMON STOCK (this “Amendment”) is entered into as of March 23, 2018, by and between SVB FINANCIAL GROUP (successor by assignment from Silicon Valley Bank) with an office located at 3003 Tasman Drive, Santa Clara, California 95054 (“SVB” and, together with any successor or permitted assignee or transferee of the Warrant (as defined below) or of any shares issued upon exercise thereof, “Holder”), and NUVECTRA CORPORATION, a Delaware corporation (“Company”) with offices located 5830 Granite Parkway, Suite 1100, Plano, TX 75024.

 

Recitals

 

A.         Company and Holder have entered into that certain Warrant to Purchase Common Stock dated as of March 18, 2016 (as amended from time to time, the “Warrant”) pursuant to which Holder has the right to acquire fully paid and non-assessable shares of Common Stock of the Company, subject to adjustment as set forth therein and otherwise on the terms set forth therein.

 

B.           Company and Holder have agreed to amend the Warrant to clarify the defined terms Number of Shares of Common Stock and Warrant Price.

 

Agreement

 

Now, Therefore, in consideration of the foregoing recitals and other good and valuable consideration, the receipt and adequacy of which is hereby acknowledged, and intending to be legally bound, the parties hereto agree as follows:

 

1.            Definitions. Capitalized terms used but not defined in this Amendment shall have the meanings given to them in the Warrant.

 

2.            Amendments. 

 

2.1     Number of Shares of Common Stock. The defined term Number of Shares of Common Stock, which appears on the first page of the Warrant, hereby is amended and restated as follows:

 

Number of Shares of Common Stock: 56,533 (the “Initial Term A Shares”); 22,844 (the “Initial Term B Shares”); and 30,245 (the “New Term B Shares”).

 

2.2     Warrant Price. The defined term Warrant Price, which appears on the first page of the Warrant, hereby is amended and restated as follows:

 

Warrant Price:     $5.97 per share with respect to the Initial Term A Shares; $12.312 per share with respect to the Initial Term B Shares; and $9.299 per share with respect to the New Term B Shares.

 

2.3     Additional Shares. Section 1.7 of the Warrant is hereby amended and restated in its entirety as follows:

 

“1.7     Intentionally Omitted.”

 

2.4     Term and Automatic Conversion Upon Expiration. Section 5.1(b) of the Warrant is hereby amended and restated in its entirety as follows:

 

“(b)     Automatic Cashless Exercise upon Expiration. In the event that, upon the Expiration Date, the fair market value of one Share (or other security issuable upon the exercise hereof) as determined in accordance with Section 1.3 above is greater than the Warrant Price in effect on such date, then this Warrant shall automatically be deemed on and as of such date to be exercised pursuant to Section 1.2 above as to all Shares (or such other securities) for which it shall not previously have been exercised, and the Company shall, within a reasonable time, deliver a certificate representing the Shares (or such other securities) issued upon such exercise to Holder.”

 

1

 

 

3.            Representations and Warranties. To induce Holder to enter into this Amendment, Company hereby represents and warrants to Holder as follows:

 

3.1     Company has the power and authority to execute and deliver this Amendment and to perform its obligations thereunder;

 

3.2     The organizational documents of Company delivered to Holder on the Issue Date, remain true, accurate and complete and have not been amended, supplemented or restated and are and continue to be in full force and effect;

 

3.3     The execution and delivery by Company of this Amendment and the performance by Company of its obligations under the Warrant, as amended by this Amendment, have been duly authorized;

 

3.4     The execution and delivery by Company of this Amendment and the performance by Company of its obligations under the Warrant, as amended by this Amendment, do not and will not contravene (a) any law or regulation binding on or affecting Company, (b) any contractual restriction with a Person binding on Company, (c) any order, judgment or decree of any court or other governmental or public body or authority, or subdivision thereof, binding on Company, or (d) the organizational documents of Company;

 

3.5     The execution and delivery by Company of this Amendment and the performance by Company of its obligations under the Warrant, as amended by this Amendment, do not require any order, consent, approval, license, authorization or validation of, or filing, recording or registration with, or exemption by any governmental or public body or authority, or subdivision thereof, binding on Company; and

 

3.6     This Amendment has been duly executed and delivered by Company and is the binding obligation of Company, enforceable against Company in accordance with its terms, except as such enforceability may be limited by bankruptcy, insolvency, reorganization, liquidation, moratorium or other similar laws of general application and equitable principles relating to or affecting creditors’ rights.

 

4.            Counterparts. This Amendment may be executed in any number of counterparts and all of such counterparts taken together shall be deemed to constitute one and the same instrument.

 

[Balance of Page Intentionally Left Blank]

 

2

 

 

 

In Witness Whereof, the parties hereto have caused this Amendment to be duly executed and delivered as of the date first written above.

 

	
			COMPANY:

			 

			NUVECTRA CORPORATION

			 

			 

			By:        /s/ Walter Z. Berger                             

			Name:   Walter Z. Berger                                  

			Title:     COO/CFO                                            

			 

			 

			SVB:

			 

			SVB FINANCIAL GROUP

			 

			 

			By:        /s/ Kevin Fleischman                             

			Name:   Kevin Fleischman                                  

			Title:     Director                                                  

				 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

[Signature Page to First Amendment to Warrant to Purchase Common Stock – SVB Financial Group]Exhibit

Exhibit 4.1

Second SUPPLEMENTAL INDENTURE (this “Supplemental Indenture”), dated as of February 12, 2018, between Northern Indiana Public Service Company, an Indiana corporation (the “Company”), and The Bank of New York Mellon, a New York banking corporation, not in its individual capacity but solely as successor trustee (the “Trustee”) under the Indenture dated as of March 1, 1988 (as supplemented, the “Indenture”) between the Company and Manufacturers Hanover Trust Company, as original trustee (the “Original Trustee”).
W I T N E S S E T H
WHEREAS, the Company executed and delivered to the Original Trustee the Indenture in order to provide for the issuance from time to time of the Company’s unsecured debentures, notes or other evidences of indebtedness (collectively, the “Securities”), to be issued in one or more series as might be determined by the Company under the Indenture in an unlimited aggregate principal amount, which may be authenticated and delivered as provided in the Indenture;
WHEREAS, Section 101 of the Indenture defines “Corporation” to include any corporation, association, company or business trust;
WHEREAS, the Company intends to become an Indiana limited liability company pursuant to a statutory conversion under the Uniform Business Organization Transactions Act of the State of Indiana (IC 23-0.6), which provides, among other things, that all debts, obligations and other liabilities of the converting entity continue as debts, obligations and other liabilities of the converted entity and that the converted entity is the same entity without interruption as the converting entity;
WHEREAS, the Company wishes to clarify any ambiguity as to whether a limited liability company is a “company” for purposes of the definitions of Company and Corporation in Section 101 of the Indenture;
WHEREAS, Section 901(9) of the Indenture provides that the Indenture may be supplemented without the consent of any Holders of Securities in order to cure any ambiguity, to correct or supplement any provision therein which may be defective or inconsistent with any other provision therein, or to make any other provisions with respect to matters or questions arising under the Indenture, provided such action shall not adversely affect the interests of the Holders of Securities of any series or any related coupons in any material respect;
WHEREAS, the Company desires and has requested that the Trustee join in the execution of this Supplemental Indenture for the purpose of curing any ambiguity regarding the definition of Corporation;
WHEREAS, the execution and delivery of this Supplemental Indenture has been authorized by resolutions of the board of directors of the Company; and
WHEREAS, all conditions precedent and requirements necessary to make this Supplemental Indenture a valid and legally binding instrument in accordance with its terms have been complied with, performed and fulfilled, and the execution and delivery hereof has been in all respects duly authorized.
NOW THEREFORE, in consideration of the foregoing and for other good and valuable consideration, the receipt and adequacy of which is hereby acknowledged, the Company and the Trustee mutually covenant and agree for the benefit of each other and the equal and ratable benefit of the Holders of Securities as follows:

ARTICLE 1
DEFINITIONS
Section 1.1Defined Terms.  As used in this Supplemental Indenture, terms defined in the Indenture or in the preamble or recitals hereto are used as so defined.  The words “herein,” “hereof” and “hereby” and other words of similar import used in this Supplemental Indenture refer to this Supplemental Indenture as a whole and not to any particular section hereof.

ARTICLE 2
REPRESENTATIONS, WARRANTIES AND AGREEMENTS OF THE COMPANY
 
Section 2.1    The Company represents, warrants and agrees as follows:

(a)It is a corporation duly organized, validly existing and in good standing under the laws of Indiana.

(b)The execution, delivery and performance by it of this Supplemental Indenture has been authorized and approved by all necessary corporate or other action on its part, and this Supplemental Indenture is its valid and legally binding obligation, enforceable against it in accordance with its terms.

(c)The conversion of the Company to become a limited liability company will not adversely affect the interests of the Holders of Securities of any series or any related coupons in any material respect.

(d)The Indenture, as supplemented by this Supplemental Indenture, shall remain in full force and effect in accordance with its terms immediately after the execution of this Supplemental Indenture.

ARTICLE 3
MISCELLANEOUS

Section 2.1Execution and Delivery.  This Supplemental Indenture shall be effective upon execution by the parties hereto.  

Section 3.2    Ratification of Indenture; Supplemental Indenture Part of Indenture.  Except as expressly amended hereby, the Indenture is in all respects ratified and confirmed and all the terms, conditions and provisions thereof shall remain in full force and effect.  This Supplemental Indenture shall form a part of the Indenture for all purposes, and every Holder of Securities heretofore or hereafter authenticated and delivered shall be bound hereby.

Section 3.3    Severability.  In case any provision in this Supplemental Indenture shall be invalid, illegal or unenforceable, the validity, legality and enforceability of the remaining provisions shall not in any way be affected or impaired thereby and such provision shall be ineffective only to the extent of such invalidity, illegality or unenforceability.

Section 3.4    Governing Law.  This Supplemental Indenture shall be governed by and construed in accordance with the internal law of the State of New York, without giving effect to any contrary conflict of laws or choice of law provisions of the law of the State of New York or any other jurisdiction. 

Section 3.5    Waiver of Jury Trial.  EACH OF THE COMPANY AND THE TRUSTEE HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR 

RELATING TO THE INDENTURE, THE SECURITIES THE TRANSACTIONS CONTEMPLATED HEREBY.

Section 3.6    Counterparts.  The parties may sign any number of copies of this Supplemental Indenture (including by electronic transmission).  Each signed copy shall be an original, but all of them together represent the same agreement.  The exchange of copies of this Supplemental Indenture and of signature pages by facsimile or PDF transmission shall constitute effective execution and delivery of this Supplemental Indenture as to the parties hereto and may be used in lieu of the original Supplemental Indenture for all purposes.  Signatures of the parties hereto transmitted by facsimile or PDF shall be deemed to be their original signatures for all purposes.

Section 3.7    Effect of Headings.  The Section headings herein are for convenience only and shall not affect the construction hereof. 

Section 3.8    Trustee.  The Trustee shall not be responsible in any manner whatsoever for or in respect of the validity or sufficiency of this Supplemental Indenture or for or in respect of the recitals contained herein, all of which recitals are made solely by the Company.

[Signature page follows]

IN WITNESS WHEREOF, the parties hereto have caused this Supplemental Indenture to be duly executed as of the day and year first above written.
	
						
	 
	 
	 
	By:
	/s/ Donald E. Brown
	 

	 
	 
	 
	Name:
	Donald E. Brown
	 

	 
	 
	 
	Title:
	Executive Vice President and Chief Financial Officer
	 

	
			
	Attest:
	 
	 

	 
	 
	 

	 
	 
	 

	By:
	/s/ Samuel K. Lee
	 

	 
	Samuel K. Lee
	 

	 
	Vice President and Corporate Secretary

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00282-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00282-of-00352.parquet"}]]